SoftBank Group Corp. tumbled to a loss in the December quarter, weighed down by a drop in the value of the Vision Fund’s public holdings, just as Masayoshi Son campaigns to raise $500 billion for the ...

Billionaire Masayoshi Son, founder and CEO of Japanese multinational investment company SoftBank Group, is one of the richest people in the world. Considered one of the most powerful investors in the ...

SoftBank's telco arm remains strong despite challenges, but high-risk AI ventures and premium valuations pose significant near-term investment risks. Learn more on SOBKY stock here.

Japan's SoftBank Group booked a surprise $2.4 billion quarterly loss on Wednesday, hit by a decline in the value of e-commerce platform Coupang and other tech companies held by its Vision Fund ...

NVIDIA's continued investment in Recursion Pharmaceuticals strengthens the view that Recursion is a favored investment within ...

SoftBank Group OpenAI as a lead partners and we have ... And as technology partners, we have of course NVIDIA, Microsoft Oracle together with OpenAI those are the industry leaders is going to ...

SoftBank Group posted a surprise quarterly loss Wednesday and the Japanese company’s revenue also missed analysts’ estimates.

Shares of Recursion Pharmaceuticals closed 23.88% higher on Friday, marking their best single-day gain in nearly two years.

SoftBank is close to finalize a $40 billion primary investment in OpenAI at a $260 billion valuation, CNBC reported on Friday. The Japanese tech and telecoms giant is reported to pay out the funding ...

SoftBank Group has entered into joint ventures with US tech giants such as Nvidia, OpenAI, Microsoft, and Oracle to invest in AI infrastructure in the US and Japan.

SoftBank Group Corp founder Masayoshi Son stood alongside US President Donald Trump to unveil the Stargate Project, an artificial intelligence (AI) venture with OpenAI that could cost US$500bil or ...